Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey

Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey

Background: Familiarity and competency in the options for stroke prevention in atrial fibrillation (AF) and the role of non-vitamin K antagonist oral anticoagulants (NOACs) may vary among primary care physicians (PCPs) from different European countries. Aims: To investigate PCP views on prescribing...

Full description

Bibliographic Details
Main Authors:	Claudio Cimminiello, Robert Hatala, Sami Pakarinen, Hernan Polo Friz, David Fitzmaurice, FD Richard Hobbs
Format:	Article
Language:	English
Published:	Royal College of General Practitioners 2018-08-01
Series:	BJGP Open
Subjects:	primary health care atrial fibrillation anticoagulants surveys and questionnaires
Online Access:	https://bjgpopen.org/content/2/3/bjgpopen18X101602

Similar Items

Anticoagulation Quality and Complications of using Vitamin K Antagonists in the Cardiac Surgery Outpatient Clinic
by: Mário Augusto Cray da Costa, et al.

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update
by: Shaojie Chen, et al.
Published: (2021-06-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study
by: Lihong Tang, et al.
Published: (2020-06-01)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
by: Joong Hyun Park, et al.
Published: (2018-12-01)

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
by: T. V. Voskresenskaya, et al.
Published: (2017-11-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
by: Nikolay Runev, et al.
Published: (2019-06-01)

Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
by: Anneka Mitchell, et al.
Published: (2019-04-01)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
by: Seongwook Han, et al.
Published: (2021-10-01)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
by: Maria Brinkmeier-Theofanopoulou, et al.
Published: (2018-04-01)

Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
by: Xiaojuan Wu, et al.
Published: (2021-09-01)

New anticoagulants in the treatment of stroke: future promise
by: Emre Kumral, et al.
Published: (2013-04-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?
by: Oktay Ergene
Published: (2019-01-01)

Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
by: Joseph R. Shaw, et al.
Published: (2020-01-01)

Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study)
by: S. Yu. Martsevich, et al.
Published: (2020-01-01)

Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF
by: David D. McManus, et al.
Published: (2019-10-01)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01)

Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
by: Giovanni Luca Botto, et al.
Published: (2021-06-01)

Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases
by: Uğur Önsel Türk, et al.
Published: (2020-04-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
by: Hans-Christoph Diener, et al.
Published: (2016-05-01)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
by: Amin A
Published: (2013-01-01)

Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
by: Naoki Shibata, MD, et al.
Published: (2017-02-01)

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01)

ANTICOAGULANT TREATMENT OF AF: FOCUS ON THE WARFARIN DOSAGE
by: Y. Kovbasniuk, et al.
Published: (2015-10-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
by: T B Kondratieva, et al.
Published: (2017-09-01)

Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
by: Aleix Cases, et al.
Published: (2021-09-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Anticoagulant Drugs
Published: (2018)

Is therapeutic anticoagulation improving renal outcomes in COVID-19?
by: Sohaib Roomi, et al.
Published: (2020-07-01)